Recent advances in mRNA technology for cancer vaccines show promise with improved stability, targeted delivery, and AI-driven antigen design, transforming immunotherapy approaches. Cutting-edge mRNA v...
Breakthrough cubosome technology enhances bioavailability of curcumin and berberine, offering precise pancreatic beta-cell targeting and improved glycemic control in preclinical trials, challenging tr...
